Solid Tumors Targeted in New CAR T-Cell Immunotherapy Trial
Seattle Children’s has opened a chimeric antigen receptor (CAR) T-cell immunotherapy trial for children and young adults with relapsed or refractory non-central nervous system…
Read More...
Read More...
